首页|乳腺癌患者他莫昔芬治疗致眼毒性的荟萃分析

乳腺癌患者他莫昔芬治疗致眼毒性的荟萃分析

扫码查看
目的 利用荟萃分析方法对他莫昔芬治疗乳腺癌致眼部疾病进行临床特征、相关因素研究.方法 应用文献检索策略中提及的数据库及关鍵词等综合检索1980~2016年已发表的关于他莫昔芬治疗乳腺癌引起眼睛毒性反应的性的有关文献.查阅文献,并提取数据信息,通过revman5.1.7统计分析.结果 他莫昔芬的眼毒性一般出现在服用后1~100个月不等,最为多见的眼部病变为黄斑水肿和黄斑结晶等眼底病变,若不及时处理,致盲率高.他莫昔芬眼毒性可能与体内浓度、累计使用剂量、年龄成正相关,与患者的代谢率、眼部疾病史等有一定关系,需进一步研究证实.结论 临床治疗乳腺癌使用他莫昔芬,应重视观察其眼毒性,及时更换药品.
A meta-analysis of eye toxicity induced by tamoxifen in breast cancer patients
Objective Methods of meta-analysis was used to investigate the clinical characteristics, related factors of ocular diseases caused by Tamoxifen.MethodsThe literature and key words in the literature search strategy were used to search the literatures related to the toxicity of tamoxifen in the treatment of breast cancer from 1980 to 2016.Refer to the literature, and extract the data information, use revman 5.1.7 statistical analysis.Results Tamoxifen was taken after t unilateral breast cancer resection by the patient,a sharp decline in visual acuity was found at the third month of taking Tamoxifen, and then the hospital diagnosed it was neuropapillitis.The analysis results show that the ocular toxicity of Tamoxifen was generally appeared after taking 1month to 100months.The most common eye diseases that result in Tamoxifen were macular edema and macular crystallization, although the cure rate was high, but if not treated ocular disease in time, blindness rate was high too.Ocular toxicity may be positive correlated with the cumulative dose of Tamoxifen and Tamoxifen concentration.The incidence rate may also positive correlated with age.Adverse reactions may be related to the metabolic rate, eye disease history and so on.Conclusion The clinical treatment of breast cancer treated with Tamoxifen, should pay attention to the ocular toxicity, replace drugs timely when there is any ADR that could not be tolerate.

breast cancertamoxifenocular toxicityMeta-analysis

周岳娟、赵静、毛艳菲、陈莎

展开 >

丽水市中心医院 药学部,浙江 丽水 323000

乳腺癌术后 他莫昔芬 眼毒性 荟萃分析

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(7)
  • 6